University, Pfizer extend biomedical research collaboration agreement

The University and pharmaceutical company Pfizer Inc. will collaborate more closely under a new biomedical research agreement that has the potential to move discoveries from the laboratory bench to patients’ bedsides more quickly. The five-year, $25 million agreement represents a new model of partnership between academia and industry.

1,000 human genomes to be sequenced

The School of Medicine will play a leading role in an international collaboration to sequence the genomes of 1,000 individuals by participating in the ambitious 1,000 Genomes Project, designed to create the most detailed picture to date of human genetic variation and assist in the identification of many genetic factors underlying common diseases.

Moss protein plays role in Alzheimer’s disease

Preventing Alzheimer’s disease is a goal of Raphael Kopan, Ph.D., professor of molecular biology and pharmacology at the Washington University School of Medicine. The moss plant Physcomitrella patens, studied in the laboratory of Ralph S. Quatrano, Ph.D., the Spencer T. Olin Professor and chair of the biology department on WUSTL’s Danforth Campus, might inch Kopan toward that goal.

Arts appreciation

Photo by Robert BostonThe School of Medicine Arts Commission’s annual art show features a variety of art by School of Medicine students, faculty and staff and will be on display through Feb. 15.
View More Stories